Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...
The purpose of this study is to learn more about treatment for patients with mitral valve regurgitation with the use of the Medtronic Intrepid™ device. This study is designed to learn if the Medtronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback